Risk Factors and Deep Learning Model for CI-AKI
- Conditions
- AKI - Acute Kidney Injury
- Registration Number
- NCT06596785
- Lead Sponsor
- Xiao Li，MD
- Brief Summary
Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent.
- Detailed Description
Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent. Despite the frequent use of iodinated contrast agents in medical investigations, predictive models for CI-AKI are scarce. This study aimed to construct and validate interpretable deep learning models for the early risk prediction of acute kidney injury (AKI) associated with iodinated contrast agents.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 2000
- patients who received iodinated contrast agents during hospitalization
- age ≥ 18 years
- hospitalization length ≥ 48 hours
- at least two serum creatinine tests during hospitalization
- patients with stage 4 or 5 chronic kidney disease prior to admission
- patients undergoing hemodialysis, hemofiltration or peritoneal before admission
- a history of nephrectomy or kidney transplantation during hospitalization
- incomplete clinical information
- Serum creatinine always ≤ 40 μmol/L during hospitalization
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AKI Completed through study, up to half a year During the patient's hospitalization, acute kidney injury occurred after the use of Iodinated contrast media
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital
🇨🇳Jinan, Shandong, China